Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-5822|5|1|139-148

ISSN： 2055-5822

Source： ESC HEART FAILURE, Vol.5, Iss.1, 2018-02, pp. : 139-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Established and novel biomarkers in ST-elevation myocardial infarction

By Waks Jonathan W   Scirica Benjamin M  

Future Cardiology, Vol. 7, Iss. 4, 2011-07 ,pp. : 523-546

Future Medicine

Access to resources Recommend Favorite

Targeting Hypertensive Myocardial Fibrosis

By Ciulla Michele M.   Paliotti Roberta   Cuspidi Cesare  

High Blood Pressure & Cardiovascular Prevention, Vol. 12, Iss. 4, 2005-01 ,pp. : 225-230

Adis International

Access to resources Recommend Favorite

Mineralocorticoid Receptor Antagonist Pretreatment to MINIMISE Reperfusion Injury After ST‐Elevation Myocardial Infarction (The MINIMISE STEMI Trial): Rationale and Study Design

By  

Clinical Cardiology, Vol. 38, Iss. 5, 2015-05 ,pp. : 259-266

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Effect of Remote Ischemic Conditioning and Glyceryl Trinitrate on Perioperative Myocardial Injury in Cardiac Bypass Surgery Patients: Rationale and Design of the ERIC‐GTN Study

By  

Clinical Cardiology, Vol. 38, Iss. 11, 2015-11 ,pp. : 641-646

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cellular and molecular pathways to myocardial necrosis and replacement fibrosis

By Gandhi Malay   Kamalov German   Shahbaz Atta   Bhattacharya Syamal   Ahokas Robert   Sun Yao   Gerling Ivan   Weber Karl  

Heart Failure Reviews, Vol. 16, Iss. 1, 2011-01 ,pp. : 23-34

Springer Publishing Company

Access to resources Recommend Favorite